ARTICLES BY JULIO G. MARTINEZ-CLARK

• LATAM's Regulatory Framework For Medtech Early Feasibility Studies

  11/11/2022

  Latin America is a compelling region to conduct medtech early feasibility studies due to its ethnically diverse population, its high rate of urbanization, and more. Here, the author spotlights Colombia, Brazil, and Mexico as the hotspots for medtech feasibility studies in Latin America. 

• Latin America's Landscape For Medtech Clinical Trials

  7/5/2022

  This article examines the need to conduct medtech clinical trials outside the U.S. and explores the growth of these trials in Latin America, particularly in Colombia and Paraguay. It also addresses critical success factors and provides recommendations to ensure cost-effective, ethical, and quality EFS and FIH medtech clinical trials in the region.

• The Opportunities For Conducting Vaccine Clinical Research In Latin America

  6/28/2022

  A few decades ago, the development of global clinical research that integrates low- and middle-income countries was considered a dream. Now it is a pressing need. This article discusses the history of vaccine research in Latin America, how the region could help solve the vaccine clinical trial diversity problem in the U.S., and why the region is a desirable destination for such clinical research. 

• Latin America: A Compelling Region To Conduct Your Clinical Trials

  6/7/2022

  This article examines the need to conduct clinical trials outside the U.S., addresses the recruitment crisis in the U.S., reviews the incentives for clinical trials overseas, and explores the growth of clinical trials in Latin America. Colombia is highlighted as a country that stands out as ripe with opportunity.

• Should You Conduct Your Medical Device Clinical Trial In Latin America?

  7/30/2018

  Bilingual U.S. board-certified physicians who have a track record of research and publications and and the fact that trial costs are significantly lower in the region, makes Latin America very attractive for U.S. life sciences companies looking to conduct cost-effective and ethical OUS clinical trials.